Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Abrams

Showing results (71-80 of 371) with videos related to

Pageof 38
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTLE S Bergmann-Leitner, S I Abrams
The Journal of School Health|March 1, 1972
A suggested school mental health programR S Abrams, M Vanecko, I Abrams
Cancer Immunology, Immunotherapy : CII|August 15, 2000
Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attackE S Bergmann-Leitner, S I Abrams
Women'S Health (London, England)|April 30, 2010
Can clinicians now assure their breast cancer patients that soyfoods are safe?Mark Messina, Donald I Abrams, Mary Hardy
The Journal of General Physiology|October 30, 2009
THE STRUCTURE OF THE COLLODION MEMBRANE AND ITS ELECTRICAL BEHAVIOR : I. THE BEHAVIOR AND PROPERTIES OF COMMERCIAL COLLODIONK Sollner, I Abrams, C W Carr
The Journal of General Physiology|October 30, 2009
THE STRUCTURE OF THE COLLODION MEMBRANE AND ITS ELECTRICAL BEHAVIOR : II. THE ACTIVATED COLLODION MEMBRANEK Sollner, I Abrams, C W Carr
Cancer Immunology, Immunotherapy : CII|January 5, 2002
Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytesE S Bergmann-Leitner, S I Abrams
Cellular Immunology|June 21, 2001
Positive and negative consequences of soluble Fas ligand produced by an antigen-specific CD4(+) T cell response in human carcinoma immune interactionsE S Bergmann-Leitner, S I Abrams
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1985
Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanismZ Brahmi, R A Bray, S I Abrams
Advances in Experimental Medicine and Biology|January 1, 1985
Lymphadenopathy: end-point prodrome? Update of a 36-month prospective studyD I Abrams, T Mess, P A Volberding
Pageof 38

Showing results (71-80 of 371) with videos related to

Sort By:
Pageof 38
Journal of Immunology (Baltimore, Md. : 1950)|April 26, 2000
Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTLE S Bergmann-Leitner, S I Abrams
The Journal of School Health|March 1, 1972
A suggested school mental health programR S Abrams, M Vanecko, I Abrams
Cancer Immunology, Immunotherapy : CII|August 15, 2000
Influence of interferon gamma on modulation of Fas expression by human colon carcinoma cells and their subsequent sensitivity to antigen-specific CD8+ cytotoxic T lymphocyte attackE S Bergmann-Leitner, S I Abrams
Women'S Health (London, England)|April 30, 2010
Can clinicians now assure their breast cancer patients that soyfoods are safe?Mark Messina, Donald I Abrams, Mary Hardy
The Journal of General Physiology|October 30, 2009
THE STRUCTURE OF THE COLLODION MEMBRANE AND ITS ELECTRICAL BEHAVIOR : I. THE BEHAVIOR AND PROPERTIES OF COMMERCIAL COLLODIONK Sollner, I Abrams, C W Carr
The Journal of General Physiology|October 30, 2009
THE STRUCTURE OF THE COLLODION MEMBRANE AND ITS ELECTRICAL BEHAVIOR : II. THE ACTIVATED COLLODION MEMBRANEK Sollner, I Abrams, C W Carr
Cancer Immunology, Immunotherapy : CII|January 5, 2002
Treatment of human colon carcinoma cell lines with anti-neoplastic agents enhances their lytic sensitivity to antigen-specific CD8+ cytotoxic T lymphocytesE S Bergmann-Leitner, S I Abrams
Cellular Immunology|June 21, 2001
Positive and negative consequences of soluble Fas ligand produced by an antigen-specific CD4(+) T cell response in human carcinoma immune interactionsE S Bergmann-Leitner, S I Abrams
Journal of Immunology (Baltimore, Md. : 1950)|December 1, 1985
Evidence for an early calcium-independent event in the activation of the human natural killer cell cytolytic mechanismZ Brahmi, R A Bray, S I Abrams
Advances in Experimental Medicine and Biology|January 1, 1985
Lymphadenopathy: end-point prodrome? Update of a 36-month prospective studyD I Abrams, T Mess, P A Volberding
Pageof 38